Role of glial cells in manganese neurotoxicity

Journal of Applied Toxicology

Volumn 32, Issue 5, 2012, Pages 310-317

  Filipov, Nikolay M ^a   Dodd, Celia A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Astrocytes; COX 2; Hydrogen peroxide; Inflammatory cytokines; Manganese neurotoxicity; MAPK; Microglia; NF B; Nitric oxide

Indexed keywords

MANGANESE;

ASTROCYTE; BASAL GANGLION; GLIA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MICROGLIA; NERVE CELL; NERVE CELL LESION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; SYSTEMATIC REVIEW;

ANIMALS; ASTROCYTES; CELL LINE; CYTOKINES; HUMANS; INFLAMMATION; MANGANESE; MICE; MICROGLIA; NEUROTOXICITY SYNDROMES;

EID: 84858860778     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1762     Document Type: Review

References (100)

1. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG. 2002. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 22: 1738-1751.
2. Antonini JM, Sriram K, Benkovic SA, Roberts JR, Stone S, Chen BT, Schwegler-Berry D, Jefferson AM, Billig BK, Felton CM, Hammer MA, Ma F, Frazer DG, O'Callaghan JP, Miller DB. 2009. Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure. Neurotoxicology 30: 915-925.
3. Aschner JL, Aschner M. 2005. Nutritional aspects of manganese homeostasis. Mol. Asp. Med. 26: 353-362.
4. Aschner M, Dorman DC. 2006. Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol. Rev. 25: 147-154.
5. Aschner M, Gannon M, Kimelberg HK. 1992. Manganese uptake and efflux in cultured rat astrocytes. J. Neurochem. 58: 730-735.
6. Aschner M, Erikson KM, Dorman DC. 2005. Manganese dosimetry: species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 35: 1-32.
7. Aschner M, Guilarte TR, Schneider JS, Zheng W. 2007. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 221: 131-147.
8. Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R. 2009. Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromol. Med. 11: 252-266.
9. Bae JH, Jang BC, Suh SI, Ha E, Baik HH, Kim SS, Lee MY, Shin DH. 2006. Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells. Neurosci. Lett. 398: 151-154.
10. Banks WA, Farr SA, Morley JE. 2002. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10: 319-327.
11. Barhoumi R, Faske J, Liu X, Tjalkens RB. 2004. Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB. Brain Res. Mol. Brain Res. 122: 167-179.
12. Bilbo SD. 2010. Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol. Learn. Mem. 94: 57-64.
13. Bilbo SD, Schwarz JM. 2009. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 3: 14.
14. Block ML, Zecca L, Hong JS. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8: 57-69.
15. Bouchard M, Mergler D, Baldwin M, Panisset M, Bowler R, Roels HA. 2007. Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14years. Am. J. Ind. Med. 50: 831-840.
16. Bowler RM, Roels HA, Nakagawa S, Drezgic M, Diamond E, Park R, Koller W, Bowler RP, Mergler D, Bouchard M, Smith D, Gwiazda R, Doty RL. 2007. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup. Environ. Med. 64: 167-177.
17. Bronstein DM, Perez-Otano I, Sun V, Mullis Sawin SB, Chan J, Wu GC, Hudson PM, Kong LY, Hong JS, McMillian MK. 1995. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704: 112-116.
18. Chang JY, Liu LZ. 1999. Manganese potentiates nitric oxide production by microglia. Brain Res. Mol. Brain Res. 68: 22-28.
19. Chen CJ, Ou YC, Lin SY, Liao SL, Chen SY, Chen JH. 2006. Manganese modulates pro-inflammatory gene expression in activated glia. Neurochem. Int. 49: 62-71.
20. Chen LW, Yung KL, Chan YS. 2005. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr. Drug Targets 6: 821-833.
21. Crittenden PL, Filipov NM. 2008. Manganese-induced potentiation of in vitro proinflammatory cytokine production by activated microglial cells is associated with persistent activation of p38 MAPK. Toxicol. Vitro 22: 18-27.
22. Crittenden PL, Filipov NM. 2011. Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J. Appl. Toxicol. 31: 1-10.
23. Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5: 137-143.
24. Dobson AW, Erikson KM, Aschner M. 2004. Manganese neurotoxicity. Ann. NY Acad. Sci. 1012: 115-128.
25. Dodd CA, Filipov NM. 2011. Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output. Neurotoxicology, in press; DOI: 10.1016/j.neuro.2011.09.002.
26. Dorman DC, Struve MF, Vitarella D, Byerly FL, Goetz J, Miller R. 2000. Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposure. J. Appl. Toxicol. 20: 179-187.
27. Dorman DC, Struve MF, Gross EA, Wong BA, Howroyd PC. 2005. Sub-chronic inhalation of high concentrations of manganese sulfate induces lower airway pathology in rhesus monkeys. Respir. Res. 6: 121.
28. dos Santos AP, Milatovic D, Au C, Yin Z, Batoreu MC, Aschner M. 2010. Rat brain endothelial cells are a target of manganese toxicity. Brain Res. 1326: 152-161.
29. Enslen H, Raingeaud J, Davis RJ. 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273: 1741-1748.
30. Erikson KM, Syversen T, Aschner JL, Aschner M. 2005. Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ. Toxicol. Pharmacol. 19: 415-421.
31. Erikson KM, Thompson K, Aschner J, Aschner M. 2007. Manganese neurotoxicity: a focus on the neonate. Pharmacol. Ther. 113: 369-377.
32. Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, Taylor WJ, Milla PJ. 1996. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347: 1218-1221.
33. Filipov NM, Seegal RF, Lawrence DA. 2005. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol. Sci. 84: 139-148.
34. Fitsanakis VA, Thompson KN, Deery SE, Milatovic D, Shihabi ZK, Erikson KM, Brown RW, Aschner M. 2009. A chronic iron-deficient/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the morris water maze. Neurotoxicol. Res. 15: 167-178.
35. Fitsanakis VA, Zhang N, Avison MJ, Erikson KM, Gore JC, Aschner M. 2011. Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol. Sci. 120: 146-153.
36. Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW. 1992. Astrocytes and Parkinson's disease. Prog. Brain Res. 94: 429-436.
37. Gao HM, Liu B, Zhang W, Hong JS. 2003. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB J. 17: 1957-1959.
38. Gavin CE, Gunter KK, Gunter TE. 1990. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem. J. 266: 329-334.
39. Gavin CE, Gunter KK, Gunter TE. 1999. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 20: 445-453.
40. Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, Johnson RW. 2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19: 1329-1331.
41. Guilarte TR, Burton NC, Verina T, Prabhu VV, Becker KG, Syversen T, Schneider JS. 2008. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J. Neurochem. 105: 1948-1959.
42. HaMai D, Bondy SC. 2004. Oxidative basis of manganese neurotoxicity. Ann. NY Acad. Sci. 1012: 129-141.
43. Hazell AS. 2002. Astrocytes and manganese neurotoxicity. Neurochem. Int. 41: 271-277.
44. Hazell AS, Norenberg MD. 1997. Manganese decreases glutamate uptake in cultured astrocytes. Neurochem. Res. 22: 1443-1447.
45. Hazell AS, Norenberg MD. 1998. Ammonia and manganese increase arginine uptake in cultured astrocytes. Neurochem. Res. 23: 869-873.
46. Hazell AS, Normandin L, Norenberg MD, Kennedy G, Yi JH. 2006. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci. Lett. 396: 167-171.
47. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB. 1999. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1410: 215-228.
48. Hirata Y, Adachi K, Kiuchi K. 1998. Activation of JNK pathway and induction of apoptosis by manganese in PC12 cells. J. Neurochem. 71: 1607-1615.
49. Jang BC. 2009. Induction of COX-2 in human airway cells by manganese: role of PI3K/PKB, p38 MAPK, PKCs, Src, and glutathione depletion. Toxicol. in Vitro 23: 120-126.
50. Kalehua AN, Taub DD, Baskar PV, Hengemihle J, Munoz J, Trambadia M, Speer DL, De Simoni MG, Ingram DK. 2000. Aged mice exhibit greater mortality concomitant to increased brain and plasma TNF-alpha levels following intracerebroventricular injection of lipopolysaccharide. Gerontology 46: 115-128.
51. Kern CH, Smith DR. 2011. Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male rats. Synapse 65: 532-544.
52. Kim J, Kim JM, Kim YK, Shin JW, Choi SH, Kim SE, Kim Y. 2007. Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism. Ind. Health 45: 497-500.
53. Kim S, Park E, Kim SJ, Chun HS. 2008. Differential role of mitogen-activated protein kinases in response to manganese treatment in substantia nigra dopaminergic neurons. J. Health Sci. 54: 244-249.
54. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20: 6309-6316.
55. Kitazawa M, Wagner JR, Kirby ML, Anantharam V, Kanthasamy AG. 2002. Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl. J. Pharmacol. Exp. Ther. 302: 26-35.
56. Kitazawa M, Anantharam V, Yang Y, Hirata Y, Kanthasamy A, Kanthasamy AG. 2005. Activation of protein kinase C delta by proteolytic cleavage contributes to manganese-induced apoptosis in dopaminergic cells: protective role of Bcl-2. Biochem. Pharmacol. 69: 133-146.
57. Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A. 1998. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Immunopharmacology 39: 167-180.
58. Kuhn DM, Francescutti-Verbeem DM, Thomas DM. 2006. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann. NY Acad. Sci. 1074: 31-41.
59. Latchoumycandane C, Anantharam V, Kitazawa M, Yang Y, Kanthasamy A, Kanthasamy AG. 2005. Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J. Pharmacol. Exp. Ther. 313: 46-55.
60. Lawson LJ, Perry VH, Dri P, Gordon S. 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170.
61. Lee ES, Yin Z, Milatovic D, Jiang H, Aschner M. 2009. Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol. Sci. 110: 156-167.
62. Liao SL, Ou YC, Chen SY, Chiang AN, Chen CJ. 2007. Induction of cyclooxygenase-2 expression by manganese in cultured astrocytes. Neurochem. Int. 50: 905-915.
63. Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. 2002. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci. 962: 318-331.
64. Liu M, Cai T, Zhao F, Zheng G, Wang Q, Chen Y, Huang C, Luo W, Chen J. 2009. Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism. Neurotoxicol. Res. 16: 42-49.
65. Liu X, Buffington JA, Tjalkens RB. 2005. NF-kappaB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Brain Res. Mol. Brain Res. 141: 39-47.
66. Liu X, Sullivan KA, Madl JE, Legare M, Tjalkens RB. 2006. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 91: 521-531.
67. Lucchini R, Albini E, Placidi D, Alessio L. 2000. Mechanism of neurobehavioral alteration. Toxicol. Lett. 112-113: 35-39.
68. Lucchini RG, Albini E, Benedetti L, Borghesi S, Coccaglio R, Malara EC, Parrinello G, Garattini S, Resola S, Alessio L. 2007. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am. J. Ind. Med. 50: 788-800.
69. Malecki EA, Lo HC, Yang H, Davis CD, Ney DM, Greger JL. 1995. Tissue manganese concentrations and antioxidant enzyme activities in rats given total parenteral nutrition with and without supplemental manganese. J. Parenter. Enteral Nutr. 19: 222-226.
70. Marreilha dos Santos AP, Santos D, Au C, Milatovic D, Aschner M, Batoreu MC. 2008. Antioxidants prevent the cytotoxicity of manganese in RBE4 cells. Brain Res. 1236: 200-205.
71. McGeer PL, McGeer EG. 2008. Glial reactions in Parkinson's disease. Mov. Disord. 23: 474-483.
72. Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M. 2009. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol. Appl. Pharmacol. 240: 219-225.
73. Moreno JA, Sullivan KA, Carbone DL, Hanneman WH, Tjalkens RB. 2008. Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. J. Neurosci. Res. 86: 2028-2038.
74. Moreno JA, Streifel KM, Sullivan KA, Legare ME, Tjalkens RB. 2009. Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicol. Sci. 112: 405-415.
75. Moreno JA, Streifel KM, Sullivan KA, Hanneman WH, Tjalkens RB. 2011. Manganese-induced NF-{kappa}B activation and nitrosative stress is decreased by estrogen in juvenile mice. Toxicol. Sci. 122: 121-133.
76. Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22: 123-144.
77. Perl DP, Olanow CW. 2007. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66: 675-682.
78. Perry VH, Newman TA, Cunningham C. 2003. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4: 103-112.
79. Prabhakaran K, Ghosh D, Chapman GD, Gunasekar PG. 2008. Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res. Bull. 76: 361-367.
80. Prabhakaran K, Chapman GD, Gunasekar PG. 2011. alpha-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-kappaB-mediated pathway. Toxicol. Mech. Meth. 21: 435-443.
81. Ramesh GT, Ghosh D, Gunasekar PG. 2002. Activation of early signaling transcription factor, NF-kappaB following low-level manganese exposure. Toxicol. Lett. 136: 151-158.
82. Roth JA, Feng L, Walowitz J, Browne RW. 2000. Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation. J. Neurosci. Res. 61: 162-171.
83. Schaumburg HH, Herskovitz S, Cassano VA. 2006. Occupational manganese neurotoxicity provoked by hepatitis C. Neurology 67: 322-323.
84. Seth P, Husain MM, Gupta P, Schoneboom A, Grieder BF, Mani H, Maheshwari RK. 2003. Early onset of virus infection and up-regulation of cytokines in mice treated with cadmium and manganese. Biometals 16: 359-368.
85. Sistrunk SC, Ross MK, Filipov NM. 2007. Direct effects of manganese compounds on dopamine and its metabolite Dopac: an in vitro study. Environ. Toxicol. Pharmacol. 23: 286-296.
86. Spranger M, Schwab S, Desiderato S, Bonmann E, Krieger D, Fandrey J. 1998. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism? Exp. Neurol. 149: 277-283.
87. Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N. 2001. On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. J. Parenter. Enteral Nutr. 25: 87-92.
88. Tansey MG, Goldberg MS. 2010. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37: 510-518.
89. Tomas-Camardiel M, Herrera AJ, Venero JL, Cruz Sanchez-Hidalgo M, Cano J, Machado A. 2002. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Brain Res. Mol. Brain Res. 103: 116-129.
90. Tran TT, Chowanadisai W, Lonnerdal B, Le L, Parker M, Chicz-Demet A, Crinella FM. 2002. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 23: 645-651.
91. Verina T, Kiihl SF, Schneider JS, Guilarte TR. 2011. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32: 215-226.
92. Wang T, Qin L, Liu B, Liu Y, Wilson B, Eling TE, Langenbach R, Taniura S, Hong JS. 2004. Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J. Neurochem. 88: 939-947.
93. Wedler FC, Ley BW, Grippo AA. 1989. Manganese(II) dynamics and distribution in glial cells cultured from chick cerebral cortex. Neurochem. Res. 14: 1129-1135.
94. Wise K, Manna S, Barr J, Gunasekar P, Ramesh G. 2004. Activation of activator protein-1 DNA binding activity due to low level manganese exposure in pheochromocytoma cells. Toxicol. Lett. 147: 237-244.
95. Ye SM, Johnson RW. 2001. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9: 183-192.
96. Zhang P, Hatter A, Liu B. 2007. Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol. Lett. 173: 88-100.
97. Zhang P, Wong TA, Lokuta KM, Turner DE, Vujisic K, Liu B. 2009. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol. 217: 219-230.
98. Zhang P, Lokuta KM, Turner DE, Liu B. 2010. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J. Neurochem. 112: 434-443.
99. Zhang S, Zhou Z, Fu J. 2003. Effect of manganese chloride exposure on liver and brain mitochondria function in rats. Environ. Res. 93: 149-157.
100. Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J. 2009. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 107: 156-164.